Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus etamsylate for prevention of postpartum hemorrhage in high-risk vaginal delivery
PACTR202205750416982Phase 1Completed
- Sponsor
- October 6 University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tranexamic acid, etamsylate and saline in postpartum hemorrhage (PPH) (3 arms), sponsored by October 6 University. Primary endpoints: Amount of blood loss, Complete blood picture and hematocrit change and 1 more. Started Apr 2022; status: completed.
02
Drugs
tranexamic acidetamsylatesaline
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202205750416982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202205750416982.